補è¬äŒç€Ÿã§ãã Aquestive Therapeutics, Inc. ã¯ãç±³åœããã³æµ·å€ã§æºããããŠããªãå»çããŒãºã«å¯Ÿå¿ããããã«ãããŸããŸãªè£œåã®ç¹å®ãéçºãããã³åååã«æ³šåããŠããŸããå瀟ã¯ãã¬ããã¯ã¹ã»ã¬ã¹ããŒçåçŸ€ã®æ²»çã®ããã®ã¯ããã¶ã ã®çµå£å¯æº¶æ§ãã£ã«ã è£œå€ Sympazanããªããªã€ãäŸåçã®æ²»çã®ããã®ããã¬ãã«ãã£ã³ãšããããœã³ã®èäžãã£ã«ã è£œå€ SuboxoneãååŠçæ³ããã³è¡åŸå埩ã«äŒŽãåãæ°ãšååã®æ²»çã®ããã®ãªã³ãã³ã»ããã³ã®çµå£å¯æº¶æ§ãã£ã«ã è£œå€ Zuplenz ã販売ããŠããŸããå瀟ã®ç¬èªã®è£œååè£ã«ã¯ãçºäœã®æ²»çã®ããã®ãžã¢ãŒãã ã®å£è
坿º¶æ§ãã£ã«ã è£œå€ Libervantãããã³çèçž®æ§åŽçŽ¢ç¡¬åçã®æ²»çã®ããã®ãªã«ãŸãŒã«ã®çµå£å¯æº¶æ§ãã£ã«ã è£œå€ Exservan ããããŸããå瀟ã®è€ååå補åã®ç¬èªã®ãã€ãã©ã€ã³ã«ã¯ãã¢ããã£ã©ãã·ãŒæ²»ççšã®ãšããããªã³ã®èäžãã£ã«ã 補å€ã§ãã AQST-108 ããå
ç«¯å·šå€§çæ²»ççšã®ãªã¯ãã¬ãªããã®èäžãã£ã«ã 補å€ã§ãã AQST-305 ãªã©ããããŸããããã«ãå瀟ã¯ããŒãã³ãœã³ç
ã®æç¶çãªãªãæéã®æ²»ççšã®ã¢ãã¢ã«ãã£ã³ã®èäžãã£ã«ã 補å€ã§ãã KYNMOBI ãéçºããŠããŸããAquestive Therapeutics, Inc. 㯠2004 幎ã«èšç«ããããã¥ãŒãžã£ãŒãžãŒå·ãŠã©ãŒã¬ã³ã«æ¬ç€Ÿã眮ããŠããŸãã